trimethylamine has been researched along with Cancer of Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, YN; Jeon, YC; Kang, JH; Kang, JS; Lee, JN; Park, CS; Park, HK; Ryu, SD; Yi, HG; Yu, TM | 1 |
1 other study(ies) available for trimethylamine and Cancer of Liver
| Article | Year |
|---|---|
Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
Topics: Adult; Ascorbic Acid; Carcinoma, Hepatocellular; Dithiothreitol; Enzyme Inhibitors; Hepatitis B, Chronic; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Methylamines; Microsomes, Liver; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitrosation; Oxygenases; Ranitidine; Recombinant Proteins; Thioamides | 2004 |